The United States patient at home testing kits market size is anticipated to grow at a CAGR of 7.94% during the forecast period of 2024-2032, driven by the increasing prevalence of infectious viruses and diseases along with the increasing awareness about self-test kits.
Patient at home testing kits is used to test for particular infection or disease in a person at home. These self-tests are also called home tests or at home tests and over the counter tests. These at-home test kits can simply be used at home with simple instructions to follow. These test kits are convenient, easily available and affordable to be used by anyone. These at-home test kits are reliable and generate almost accurate results. These at-home test kits are also used to pre-diagnose the current medical condition of a patient.
With the use of these at-home test kits the results could be generated in about 10-15 minutes. These tests are most probably antigen tests. In case of detecting viruses these at-home test kits could be fast to generate results but the accuracy of the results may be unreliable as they are different from regular PCR tests.
The market has been witnessing rapid growth and is expected to witness further growth in the coming years with the increasing rate of people visiting healthcare facilities, such as hospitals, clinics frequently in case of the smallest discomfort in their health. The key trends supporting the United States patient at home testing kits market growth include the increasing awareness about self-test kits and related products in the United States, the people are now getting more attracted towards using self-test kits than visit any health care facility first. They like to pre-diagnose themselves first before visiting a healthcare facility or a healthcare professional, which is why the demand is growing.
At-home or self-testing kits are easily available at pharmacies, and it has become extremely easy to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits.
Market Breakup by Test Type
Market Breakup by Sample
Market Breakup by Age Group
Market Breakup by Usage
Market Breakup by Distribution Channel
The increasing prevalence of infectious viruses and diseases is primarily driving the market growth. The adoption of these at-home testing kits by several distribution channels, including offline, pharmacies, and online pharmacies, among others, has rapidly contributed to the growth of the at-home test kits in the United States market, which makes it easier for anyone to avail them at their wish.
Additionally, the increasing technological advancement to enhance the generated outcomes by the test kits is also contributing to the United States patient at home testing kits market growth.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
|Scope of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Test Type
|Breakup by Sample
|Breakup by Age Group
|Breakup by Usage
|Breakup by Distribution Channel
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 United States Patient at Home Testing Kits Market Overview
3.1 United States Patient at Home Testing Kits Market Historical Value (2017-2023)
3.2 United States Patient at Home Testing Kits Market Forecast Value (2024-2032)
4 United States Patient at Home Testing Kits Market Landscape
4.1 United States Patient at Home Testing Kits Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 United States Patient at Home Testing Kits Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Use
5 United States Patient at Home Testing Kits Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 United States Patient at Home Testing Kits Market Segmentation
6.1 United States Patient at Home Testing Kits Market by Test Type
6.1.1 Market Overview
6.1.2 Blood Glucose Testing
6.1.3 Pregnancy and Fertility Testing
6.1.4 HIV Testing
6.1.5 Cholesterol Testing
6.1.6 Urine Testing
6.1.7 COVID-19 Testing
6.1.8 Drug Abuse Testing
6.2 United States Patient at Home Testing Kits Market by Sample
6.2.1 Market Overview
6.3 United States Patient at Home Testing Kits Market by Age Group
6.3.1 Market Overview
6.4 United States Patient at Home Testing Kits Market by Usage
6.4.1 Market Overview
6.5 United States Patient at Home Testing Kits Market by Distribution Channel
6.5.1 Market Overview
6.5.2 Retail Pharmacy Stores
7 Patent Analysis
7.1 Analysis by Type of Patent
7.2 Analysis by Publication year
7.3 Analysis by Issuing Authority
7.4 Analysis by Patent Age
7.5 Analysis by CPC Analysis
7.6 Analysis by Patent Valuation
7.7 Analysis by Key Players
8 Grants Analysis
8.1 Analysis by year
8.2 Analysis by Amount Awarded
8.3 Analysis by Issuing Authority
8.4 Analysis by Grant Application
8.5 Analysis by Funding Institute
8.6 Analysis by NIH Departments
8.7 Analysis by Recipient Organization
9 Funding Analysis
9.1 Analysis by Funding Instances
9.2 Analysis by Type of Funding
9.3 Analysis by Funding Amount
9.4 Analysis by Leading Players
9.5 Analysis by Leading Investors
9.6 Analysis by Geography
10 Partnership and Collaborations Analysis
10.1 Analysis by Partnership Instances
10.2 Analysis by Type of Partnership
10.3 Analysis by Leading Players
10.4 Analysis by Geography
11 Regulatory Framework
11.1 Regulatory Overview
11.1.1 US FDA
11.1.2 EU EMA
11.1.3 INDIA CDSCO
11.1.4 JAPAN PMDA
12 Supplier Landscape
12.1 Lucira Health Inc.
12.1.1 Financial Analysis
12.1.2 Product Portfolio
12.1.3 Demographic Reach and Achievements
12.1.4 Mergers and Acquisitions
12.2 Essenlix Corporation
12.2.1 Financial Analysis
12.2.2 Product Portfolio
12.2.3 Demographic Reach and Achievements
12.2.4 Mergers and Acquisitions
12.3 Abbott Laboratories, Inc.
12.3.1 Financial Analysis
12.3.2 Product Portfolio
12.3.3 Demographic Reach and Achievements
12.3.4 Mergers and Acquisitions
12.4 Roche Diagnostics Corporation
12.4.1 Financial Analysis
12.4.2 Product Portfolio
12.4.3 Demographic Reach and Achievements
12.4.4 Mergers and Acquisitions
12.5 Siemens Medical Solutions USA, Inc.
12.5.1 Financial Analysis
12.5.2 Product Portfolio
12.5.3 Demographic Reach and Achievements
12.5.4 Mergers and Acquisitions
12.6 Thermo Fischer Scientific, Inc.
12.6.1 Financial Analysis
12.6.2 Product Portfolio
12.6.3 Demographic Reach and Achievements
12.6.4 Mergers and Acquisitions
12.7 Scanwell Health, Inc.
12.7.1 Financial Analysis
12.7.2 Product Portfolio
12.7.3 Demographic Reach and Achievements
12.7.4 Mergers and Acquisitions
12.8 Quidel Corporation
12.8.1 Financial Analysis
12.8.2 Product Portfolio
12.8.3 Demographic Reach and Achievements
12.8.4 Mergers and Acquisitions
12.9 GE Healthcare, Inc.
12.9.1 Financial Analysis
12.9.2 Product Portfolio
12.9.3 Demographic Reach and Achievements
12.9.4 Mergers and Acquisitions
12.10 ACON Laboratories, Inc.
12.10.1 Financial Analysis
12.10.2 Product Portfolio
12.10.3 Demographic Reach and Achievements
12.10.4 Mergers and Acquisitions
13 United States Patient At Home Testing Kits Market - Distribution Model (Additional Insight)
13.2 Potential Distributors
13.3 Key Parameters for Distribution Partner Assessment
14 Key Opinion Leaders (KOL) Insights (Additional Insight)
15 Company Competitiveness Analysis (Additional Insight)
15.1 Very Small Companies
15.2 Small Companies
15.3 Mid-Sized Companies
15.4 Large Companies
15.5 Very Large Companies
16 Payment Methods (Additional Insight)
16.1 Government Funded
16.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market is anticipated to grow at a CAGR of 7.94% during the forecast period of 2024-2032.
The increasing prevalence of infectious viruses and diseases, along with the high availability of these at-home testing kits, are among the major factors driving the market growth.
The increasing awareness about self-test kits and related products is among the major trends driving the market growth.
The different types of tests in the market are blood glucose testing, pregnancy and fertility testing, HIV testing, cholesterol testing, urine testing, COVID-19 testing, and drug abuse testing, among others.
The different types of samples that can be collected from patient at home testing kits are blood, urine, and saliva, among others.
The age groups that can use the patient at home testing kits are pediatric, adult, and geriatric.
The different usages include disposable contact lenses and reusable contact lenses.
The different distribution channels are retail pharmacy stores, hypermarket/supermarket, and e-commerce.
Key players involved in the market are Lucira Health Inc., Essenlix Corporation, Abbott Laboratories, Inc., Siemens Medical Solutions USA, Inc., Thermo Fischer Scientific, Inc., Scanwell Health, Inc., Quidel Corporation, GE Healthcare, Inc., ACON Laboratories, Inc., and Roche Diagnostics Corporation.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.